Activity of the ERK1/2 component of the mitogenic arm of the insulin signaling pathway in skeletal muscle is reported to be upregulated in women with PCOS, resulting in phosphorylation predominantly at Ser312, which may then result in reduced activation of the metabolic portions of the pathway and insulin resistance [78]. The gene discussed is MAPK3; the disease is polycystic ovary syndrome.